Innovage Holding Corp. (INNV) vs Kailera Therapeutics, Inc. (KLRA)
A side-by-side comparison of Innovage Holding Corp. and Kailera Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INNV
Innovage Holding Corp.
$9.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
KLRA
Kailera Therapeutics, Inc.
$10.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — INNV vs KLRA
growth of $100 · dividends reinvested · last 1yINNV +9.2% (+9.2%/yr)KLRA -58.3% (-58.3%/yr)INNV compounded faster over this window
INNV KLRA
INNV vs KLRA: by the numbers
- •KLRA is the larger company ($1.40B vs $1.22B market cap).
- •Both run net losses; KLRA's is the smaller (0.00% vs -0.26% net margin).
Metrics side by side
Valuation
| Metric | INNV | KLRA |
|---|---|---|
| Forward P/E | 20.44 | N/A |
| P/S ratio | 1.23 | N/A |
| P/B ratio | 5.19 | 1.25 |
| EV / EBITDA | 14.35 | N/A |
| FCF yield | 4.13% | N/A |
Profitability
| Metric | INNV | KLRA |
|---|---|---|
| Gross margin | 21.39% | 0.00% |
| Operating margin | 6.39% | 0.00% |
| Net margin | -0.26% | 0.00% |
| ROE | -1.08% | N/A |
| ROIC | 9.48% | -24.52% |
Growth (annualized)
| Metric | INNV | KLRA |
|---|---|---|
| Revenue CAGR (5Y) | 9.19% | N/A |
| Total return CAGR (5Y) | 5.55% | N/A |
Go deeper
Dig into the metrics
Innovage ROEKailera Therapeutics ROEInnovage operating marginKailera Therapeutics operating marginInnovage revenue growthKailera Therapeutics revenue growthInnovage free cash flowKailera Therapeutics free cash flow
Innovage & Kailera Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.